<p>The present invention relates to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or condition.</p>
申请公布号
AU2012214029(A1)
申请公布日期
2013.08.29
申请号
AU20120214029
申请日期
2012.02.10
申请人
MERCK SHARP & DOHME CORP.
发明人
KARSTENS, WILLEM FREDERIK JOHAN;STELT, MARIO VAN DER;CALS, JOS;AZEVEDO, RITA CORTE REAL GONCALVES;BARR, KENNETH JAY;ZHANG, HONGJUN;BERESIS, RICHARD THOMAS;ZHANG, DONGSHAN;DUAN, XIAOBANG
